Skip to content
Open menu Close menu

Clinical

ECMC The Institute, through its Clinical Director and successful bidding with the Experimental Cancer Medicine Centre, has a strong association with major clinical and translational centres in Yorkshire.  The Bradford/Leeds collaboration provides a network of experienced oncologists covering early phase tumour site specific clinical research with state-of-the-art facilities.  We integrate with world class pre-clinical and translational research scientists and hold a pivotal position within local, national and international clinical research networks.

We collaborate with:

  • Academic Department of Medical Oncology, University of Leeds
  • Cancer Research UK Clinical Centre, St James's University Hospital, Leeds
  • Part of the regional Experimental Cancer Medicine Centre (ECMC)

We have access to the following major regional clinical resources:

  • Third largest cancer centre in the UK
  • Full range of multidisciplinary teams covering all aspects of oncology
  • Over 40 oncologists locally
  • Dedicated Cancer Research UK clinical research ward and clinical research team

A core drug development team has been established within the region allowing access to a range of skills and expertise:

St James's

St James's University Hospital, Leeds

The specific group of activities include:

  • Early clinical trials
  • Pre-clinical pharmacology
  • Clinical pharmacokinetics and pharmacodynamics

We integrate with site specific teams by:

  • Close collaboration between early phase clinical team in Leeds
  • Tumour specific phase I and II studies conducted with lead clinician for tumour type

GCLP Pharmacology Laboratories

  • CRUK Two controlled access laboratories
  • Established Quality Assurance programme in line with CR-UK/ECMC national standards
  • Over 100 Standard Operating Procedures
  • Audited by CR-UK and pharma

Upcoming events

View all events »